Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Isopropamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 known ✓ | P20309 | 7/20 | 0.97 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.97 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.97 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.97 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.97 |
| ▸ | LMNA | P02545 | 1/20 | 0.97 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.44 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.44 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.44 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopropamide SCHEMBL100256 | 0.98 | CHRM3 (1.00) | KDM4ECTDSP1CHRM3CHRM2KCNH2 | |
| Isopropamide SCHEMBL3082703 | 0.97 | CHRM3 (0.97) | KDM4ECTDSP1CHRM3CHRM2KCNH2 | |
| Isopropamide SCHEMBL14672609 | 0.96 | CHRM3 (0.94) | KDM4ECTDSP1CHRM3CHRM2KCNH2 | |
| Isopropamide SCHEMBL7796559 | 0.91 | CHRM3 (0.85) | KDM4ECTDSP1CHRM3CHRM2KCNH2 | |
| Isopropamide SCHEMBL17923572 | 0.89 | KDM4E (0.79) | KDM4ECTDSP1CHRM3CHRM2KCNH2 | |
| SCHEMBL4538265 | 0.88 | CHRM3 (0.80) | KDM4ECTDSP1CHRM3CHRM2KCNH2 | |
| Ambutonium SCHEMBL11946672 | 0.79 | CHRM3 (0.67) | KDM4ECTDSP1CHRM3CHRM2KCNH2 | |
| Ambutonium SCHEMBL249674 | 0.78 | CHRM3 (0.65) | KDM4ECTDSP1CHRM3CHRM2KCNH2 | |
| SCHEMBL25341236 | 0.76 | CHRM3 (0.63) | KDM4ECTDSP1CHRM3CHRM2KCNH2 | |
| Hydrochloric Acid SCHEMBL30307081 | 0.75 | CHRM3 (0.61) | KDM4ECTDSP1CHRM3CHRM2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2682 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250144193-A1 | PROBIOTIC VACCINES AND RELATED METHODS OF USE | SALVITUS, INC. | 2025-05-08 | — | — | US | claimed |
| EP-4536236-A2 | METHODS OF MODULATING ATXN2 EXPRESSION | University of Utah Research Foundation (US) | 2025-04-16 | — | — | EP | claimed |
| EP-4479539-A2 | PROBIOTIC VACCINES AND RELATED METHODS OF USE | Salvitus, Inc. (US) | 2024-12-25 | — | — | EP | claimed |
| WO-2024178160-A2 | RECOMBINANT PHAGE, PROBIOTIC VACCINES AND THERAPEUTICS, RELATED COMPOSITIONS AND METHODS OF USE | SALVITUS, INC. (US) | 2024-08-29 | — | — | WO | claimed |
| WO-2023239747-A2 | METHODS OF MODULATING ATXN2 EXPRESSION | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2023-12-14 | — | — | WO | claimed |
| WO-2023158883-A2 | PROBIOTIC VACCINES AND RELATED METHODS OF USE | SALVITUS, INC. (US) | 2023-08-24 | — | — | WO | claimed |
| CN-110751189-B | Ellipse detection method based on perception contrast and feature selection | 北京航空航天大学 | 2022-02-22 | — | — | CN | claimed |
| US-20220008334-A1 | GASTRIC RETENTIVE DEVICES | CLEXIO BIOSCIENCES LTD. (IL) | 2022-01-13 | — | — | US | claimed |
| US-11147766-B2 | Gastric retentive devices | CLEXIO BIOSCIENCES LTD. (IL) | 2021-10-19 | — | — | US | claimed |
| US-20200187851-A1 | PERIODONTAL DISEASE STRATIFICATION AND USES THEREOF | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2020-06-18 | — | — | US | claimed |
| CN-1520818-A | Cholinesterase inhibitor pharmaceutical composition for senile dementia | ɽ����Ҷ��Ȼҩ���о���������˾ | 2004-08-18 | — | — | CN | claimed |
| WO-2004041263-A1 | NEW PHARMACEUTICAL COMPOSITIONS CONTAINING AMBROXOL AND ISOPROPAMIDE IODIDE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-05-21 | — | — | WO | claimed |
| EP-1417961-A1 | New pharmaceutical compositions containing a combination of ambroxol or bromhexine and isopropamide iodide | Boehringer Ingelheim International GmbH (DE) | 2004-05-12 | — | — | EP | claimed |
| WO-2003089012-A2 | CAVITY FILLING BIOPSY SITE MARKER | SENORX, INC. (US) | 2003-10-30 | — | — | WO | claimed |
| EP-1305355-A1 | HYDROGEL FILMS AND METHODS OF MAKING AND USING THEREFOR | The University of Utah Research Foundation (US) | 2003-05-02 | — | — | EP | claimed |
| EP-1273301-A2 | Pharmaceutical preparations based on active ingredients susceptible to illicit administration | ALTERGON S.A. (CH) | 2003-01-08 | — | — | EP | claimed |
| US-20020188196-A1 | Cavity-filling biopsy site markers | SENORX, INC. | 2002-12-12 | — | — | US | claimed |
| WO-2002006373-A1 | HYDROGEL FILMS AND METHODS OF MAKING AND USING THEREFOR | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2002-01-24 | — | — | WO | claimed |
| US-5023088-A | Drug delivery dispenser | ALZA CORPORATION (US) | 1991-06-11 | — | — | US | claimed |
| US-4824676-A | ANTICHOLINERGIC AGENT TO SUPPRESS PERSPIRATION | SCHERING CORPORATION (US) | 1989-04-25 | — | — | US | claimed |